Endovenous Ablation Interventions for Symptomatic Varicose Veins of the Legs

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP).

This report is an evidence assessment of the best available research evidence on the safety and effectiveness, cost effectiveness and budget impact of using Endovenous Laser Ablation (EVLA) or Endovenous Radiofrequency Ablation (RFA) in the management of symptomatic varicose veins of the legs due to venous reflux in working age patients when compared to conventional open surgery.

It also describes the nature varicose veins with venous reflux, the available clinical practice guidelines regarding the management of the condition, as well as the technologies currently being delivered in Alberta to treat the condition and the available system capacity for delivery of the technologies being assessed.

Section Authors:

  • Section One – Social and System Demographics: Ken Bond, Christa Harstall, Liz Dennett
  • Section Two – Technology Efficacy and Effectiveness: Paula Corabian; Ken Bond, Christa Harstall, Liz Dennett
  • Section Three – Economic Analysis: Charles Yan, Ken Bond, Anderson Chuck, Liz Dennett
  • Information Specialist: Liz Dennett

Related Reports:

Publication Type: Health Technology Assessments /
Systematic Reviews

Year of Publication: 2014

Topics: Health Economics / Healthcare Costs, Quality of Life, Therapy

Authors: IHE Institute of Health Economics

ISBN (online): 978-1-926929-23-1

INAHTA URL: http://www.inahta.org/upload/2014/14044_IHE_Endovenous ablation interventions for symptomatic varicose veins of the legs.pdf